Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jan 13 2022

Full Issue

Covid Tests Also Prove Positive When It Comes To Company Profits

For example Abbott, the maker behind the BinaxNow at-home covid tests, reported third-quarter profits up 48% compared to last year's figure. But while for many finding tests is difficult, some corporations are making it easy for staff. There are also warnings over fraudulent testing services.

CBS News: COVID-19 Test Providers Reap Profits As Consumers Pay Through The Nose 

Makers of COVID-19 testing tools are raking in billions while many consumers pay through the nose to find out if they are infected. ... Abbott Laboratories‚ maker of the BinaxNow test, one of the most popular at-home screening devices — notched $1.9 billion in third-quarter sales related to COVID-19 testing, up 48% compared to the year-ago period. The BinaxNow test alone was responsible for $1.6 billion in sales. (Cerullo, 1/12)

And not everyone is scrambling to find a test —

The Washington Post: Amid Covid Test Shortage, Corporate Employees Get Them Free 

Workers at corporate giants such as Google and JPMorgan Chase can request tests be sent to them free. At Google, employees can receive as many as 20 tests per month, even if they’re not going into the office. Delta Air Lines allows its flight staff and corporate employees to order sets of six antigen tests every three weeks. (De Vynck and Bogage, 1/13)

The New York Times: Why Some Workers Are Getting All The Covid Tests They Need

The latest Covid-19 wave has left millions of Americans scrambling for tests, braving long lines in the cold at pop-up sites or searching furiously online for kits to use at home. But for a select group of employees at some of the country’s largest companies, tests are free and often readily available. (Goldberg, Hirsch and McCabe, 1/12)

In more news about covid tests —

Dallas Morning News: Tarrant County Warns That Fraudulent COVID-19 Test Sites Are Stealing Personal Info

Tarrant County District Attorney Sharen Wilson said in a statement Wednesday that fake testing sites have popped up across the country, with scammers asking for Social Security and credit card numbers, birth dates and health insurance information. “Be careful,” Wilson said in a news release. “Research the facilities before you go, and make sure it’s a valid testing site.” The Better Business Bureau also issued a warning, urging test seekers to use caution at pop-up sites and when purchasing at-home tests. (Bahari, 1/12)

Cincinnati Enquirer: Company Linked To Complaints About 'Bogus' COVID-19 Tests At Work In Cincinnati

The company, the Center for COVID Control, is based in Illinois and claims to operate hundreds of testing sites across the country, including at least five in southwest Ohio. The other local sites on the company's website are in Finneytown, Anderson Township, West Chester Township and East Price Hill. A spokesman for the Centers for Medicare & Medicaid Services told The Enquirer on Wednesday that the government agency has "received multiple complaints from different state agencies regarding the Center for COVID Control and temporary testing sites." He did not describe the nature of those complaints, but he said all would be investigated. (Horn, 1/12)

San Francisco Chronicle: Home COVID Testing Becomes Critical Part Of Pandemic Response

As the pandemic drags on and frequent testing is normalized, home tests are becoming essential because of their convenience and immediacy, say local health officials. “I do see us moving towards this,” said Sonoma County Health Officer Dr. Sundari Mase, though she emphasized lab-based tests are better in clinical settings. Home testing can help people decide whether to get on a plane, go to school or visit an aging relative, for instance, but a lab-based test is better for someone who’s been admitted to a hospital with COVID symptoms and whose doctor is trying to diagnose and treat the illness. (Ho, 1/12)

CBS News: How Will I Be Reimbursed For Rapid COVID Tests? And Other FAQs 

Will I automatically be reimbursed the full amount? It depends. Under the guidelines, the Biden administration encourages private insurers to make tests available to members for free at the point of purchase by creating networks of preferred retailers, including pharmacies. Insurers would then reimburse the retailer, rather than the consumer, for the cost of the test. (Cerullo, 1/12)

The Washington Post: Americans Seeking Covid Tests Are Overwhelming ERs. Here’s How Other Countries Are Handling The Demand.

The United States is far from the only country battling yet another coronavirus wave coupled with a shortage of antigen and PCR tests. Here’s how some other countries are handling the surge in demand for testing. (Berger, 1/12)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
  • Tuesday, April 14
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF